Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01924676 · ClinicalTrials.gov registry record · Phase 1

Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers

A Phase 1 study of Healthy, sponsored by Pain Therapeutics.

Completed
Registry status
Phase 1
Development phase
18
Enrollment target
1
Study location

NCT01924676: Completed Phase 1 study of Healthy, sponsored by Pain Therapeutics.

NCT01924676 is a Phase 1 study of Healthy that has completed, run by Pain Therapeutics. The registered enrollment target is 18 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01924676, a Phase 1 study of Healthy, has completed, sponsored by Pain Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

To estimate the effects of food on oxycodone pharmacokinetics after administration of 40 mg doses of PF-00345439 Formulation K and to estimate its relative bioavailability compared to PF-00345439 Formulation X in the fasted state in healthy volunteers

Primary Outcome

AUC (0 - 8)= Area under the plasma concentration versus time curve (AUC) from time zero (pre-dose) to extrapolated infinite time (0 - 8). It is obtained from AUC (0 - t) plus AUC (t - 8).

Conditions Studied

Interventions

  • DRUG Oxycodone

Study Locations (1)

Maryland

  • Pfizer Investigational Site - Baltimore

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2013-08
Est. Completion 2013-10
Phase Phase 1
Pain Therapeutics

12 total trials

What the finished NCT01924676 record still lists

NCT01924676 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Oxycodone is the first listed.

NCT01924676 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01924676 about?

NCT01924676 is a clinical study titled "Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers". To estimate the effects of food on oxycodone pharmacokinetics after administration of 40 mg doses of PF-00345439 Formulation K and to estimate its relative bioavailability compared to PF-00345439 Formulation X in the fasted state in healthy volunteers

What is the current status of trial NCT01924676?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2013-08. Estimated completion is 2013-10.

What conditions does trial NCT01924676 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01924676?

The interventions under investigation include: Oxycodone (DRUG).

Who is sponsoring clinical trial NCT01924676?

This trial is sponsored by Pain Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01924676 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01924676's enrollment target sits among peer trials

18 904th of 1090 higher than 163 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01924676, the US trial registry maintained by the National Library of Medicine. NCT01924676 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.